Clinical trial
A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell…
NCT00059735 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00059735 |
|---|---|
| Title | A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma |
| Official title | A Phase II Study of E7070 in Patients With Progressive Inoperable and/or Metastatic Renal Cell Carcinoma (RCC) |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Neoplasms, Carcinoma, Renal Cell, Adenocarcinoma |
| Intervention type | Drug |
| Interventions | E7070 |
| Enrollment | 30 |
| Start date | May 1, 2002 |
| Completion | Dec 1, 2003 |
| First posted | May 7, 2003 |
| Last update posted | Mar 5, 2008 |
| Countries | France, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: